Moondust Ventures Invests in QurieGen to Accelerate AI-Driven Precision Medicine

Date

April 6, 2025

Category

Digital Health

Summary

Moondust Ventures has joined the €2.2 million pre-seed round of QurieGen, a pioneering biotech startup using AI-driven single-cell analysis to revolutionize drug discovery and enable breakthroughs in precision medicine.

Moondust Ventures is proud to announce its participation in the €2.2 million pre-seed funding round of QurieGen, a trailblazing biotech startup that is transforming the future of drug discovery.

QurieGen leverages AI-powered single-cell analysis through its proprietary platform—often described as a “Google Maps for cells”—to deliver deep insights into cellular behavior. This cutting-edge approach is opening new doors in precision medicine and the development of next-generation therapeutics.

You can find more information here.